Literature DB >> 20691505

NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors.

Christopher M Morris1, Clive G Ballard, Louise Allan, Elise Rowan, Sally Stephens, Michael Firbank, Gary A Ford, Rose Anne Kenny, John T O'Brien, Raj N Kalaria.   

Abstract

Stroke is a major risk factor for the development of dementia in the elderly. It is unclear which genes influence risk of delayed dementia after stroke. We tested a single nucleotide polymorphism (SNP) in endothelial nitric oxide synthase (NOS3) gene at codon 298 (single-nucleotide polymorphism rs1799983; p.Asp298Glu) in a cohort of 355 older (>75 years) stroke survivors, who had detailed cognitive assessments from 3 months poststroke, i.e., baseline when the patients were free of dementia and subsequently at annual intervals. Of these, 253 participants were genotyped for polymorphisms in NOS3 and apolipoprotein E (APOE). Our analysis showed that homozygosity for NOS3 TT rather than the GT or GG genotype was a significant factor in the development of dementia. The presence of TT genotype increased risk of incident dementia compared with GG genotype; hazard ratio, 3.14 (95% confidence interval, 1.64-5.99; p = 0.001). We hypothesize that this may be mediated by reduction of nitric oxide production and cerebral perfusion. Our findings, if replicated widely, have implications for treatments to ameliorate cognitive decline in stroke survivors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691505     DOI: 10.1016/j.neurobiolaging.2010.06.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  Close association between polymorphisms of the nitric oxide synthetase 3 gene and neurological disorders other than stroke.

Authors:  Shailendra Kapoor
Journal:  Int J Gen Med       Date:  2012-05-11

Review 2.  Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.

Authors:  Fred Stephen Sarfo; Rufus Akinyemi; George Howard; Virginia J Howard; Kolawole Wahab; Mary Cushman; Deborah A Levine; Adesola Ogunniyi; Fred Unverzagt; Mayowa Owolabi; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2020-02-19       Impact factor: 4.553

Review 3.  Post-stroke dementia - a comprehensive review.

Authors:  Milija D Mijajlović; Aleksandra Pavlović; Michael Brainin; Wolf-Dieter Heiss; Terence J Quinn; Hege B Ihle-Hansen; Dirk M Hermann; Einor Ben Assayag; Edo Richard; Alexander Thiel; Efrat Kliper; Yong-Il Shin; Yun-Hee Kim; SeongHye Choi; San Jung; Yeong-Bae Lee; Osman Sinanović; Deborah A Levine; Ilana Schlesinger; Gillian Mead; Vuk Milošević; Didier Leys; Guri Hagberg; Marie Helene Ursin; Yvonne Teuschl; Semyon Prokopenko; Elena Mozheyko; Anna Bezdenezhnykh; Karl Matz; Vuk Aleksić; DafinFior Muresanu; Amos D Korczyn; Natan M Bornstein
Journal:  BMC Med       Date:  2017-01-18       Impact factor: 8.775

4.  "Is all the stuff about neurons necessary?" The development of lay summaries to disseminate findings from the Newcastle Cognitive Function after Stroke (COGFAST) study.

Authors:  Sarah Barnfield; Alison Clara Pitts; Raj Kalaria; Louise Allan; Ellen Tullo
Journal:  Res Involv Engagem       Date:  2017-09-11

Review 5.  Genetic Factors of Nitric Oxide's System in Psychoneurologic Disorders.

Authors:  Regina F Nasyrova; Polina V Moskaleva; Elena E Vaiman; Natalya A Shnayder; Nataliya L Blatt; Albert A Rizvanov
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

6.  Systems-wide analysis unravels the new roles of CCM signal complex (CSC).

Authors:  Johnathan Abou-Fadel; Mariana Vasquez; Brian Grajeda; Cameron Ellis; Jun Zhang
Journal:  Heliyon       Date:  2019-12-02

7.  Association of NOS3-c.894G>T transversion with susceptibility to metabolic syndrome in Azar-cohort population: A case-control study and in silico analysis of the SNP molecular effects.

Authors:  Ensiyeh Seyedrezazadeh; Elnaz Faramarzi; Nasim Bakhtiyari; Atefeh Ansarin; Neda Gilani; Amir Amiri-Sadeghan; Maryam Seyyedi; Khalil Ansarin; Younes Aftabi
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.